130 results on '"Razavi-Shearer, Devin"'
Search Results
2. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
3. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
4. WED-466 The cost of HBV and HCV elimination in Ethiopia based on the current disease burden
5. WED-448 Peak mortality is on the horizon: will we flatten the curve?
6. WED-437 Viral hepatitis elimination: scale up now to avert the worst yet to come
7. The economic argument for hepatitis B treatment simplification and expansion
8. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
9. Global HBV disease burden and current care gaps
10. Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study
11. A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia
12. Global prevalence of hepatitis C virus in children in 2018: a modelling study
13. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
14. Risk of developing cancer-comparison of HBV, HCV and smoking
15. Reimplementation of a revamped cost-effective national elimination strategy is the only way Brazil moves towards eliminating HCV
16. Trends in hepatitis B and hepatitis C related hepatocellular carcinoma, 2015 to 2030
17. Population adjusted prevalence of hepatitis delta virus in 21 countries and territories
18. The impact of immigration on hepatitis B burden in the United States: a modelling study
19. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
20. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
21. Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries
22. Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050
23. Cost‐effectiveness of treating all hepatitis B–positive individuals in the United States.
24. The elimination of hepatitis C in the cherokee Nation: the impact of harm reduction
25. The disease burden of hepatitis B and hepatitis C from 2015 to 2030: the long and winding road
26. Evaluation of global progress towards HBV and HCV elimination
27. The impact of vaccination on the global and regional pediatric prevalence of hepatitis B from 1985 to 2022
28. Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis
29. WED-474 Population-based hepatitis C screening in Lithuania: 18-month results of the program and scenarios for achieving WHO elimination targets
30. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting
31. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world
32. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
33. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
34. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
35. Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
36. Impact of COVID-19 on global HCV elimination efforts
37. FRI-212 - Risk of developing cancer-comparison of HBV, HCV and smoking
38. FRI-170 - Reimplementation of a revamped cost-effective national elimination strategy is the only way Brazil moves towards eliminating HCV
39. TOP-096 - Trends in hepatitis B and hepatitis C related hepatocellular carcinoma, 2015 to 2030
40. FRI-116 - Population adjusted prevalence of hepatitis delta virus in 21 countries and territories
41. Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
42. Estimating the health impact of vaccination against 10 pathogens in 98 low and middle income countries from 2000 to 2030
43. Chronic hepatitis C in the Czech Republic: Forecasting the disease burden
44. Estimating the Health Impact of Vaccination Against 10 Pathogens in 98 Low and Middle Income Countries from 2000 to 2030
45. The case for simplifying and using absolute targets for viral hepatitis elimination goals.
46. Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission – Authors' reply
47. Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden
48. Preoperative Coagulation Profile Testing to Predict Blood Loss in Complex Spine Surgery: Identifying the Patient at Risk
49. A Comparative Analysis of Lumbosacral Fixation Strengths: What is Best in a Long Fusion?
50. Medical Marijuana Use Characteristics in Patients with Chronic Spine Pain Disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.